ArticlePloS one2023

A targeted isotope dilution mass spectrometry assay for osteopontin quantification in plasma of metastatic breast cancer patients.

Andrew Leslie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.